Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

533 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prospective randomized study evaluating the efficacy of the spherical adsorptive carbon AST-120 in chronic kidney disease patients with moderate decrease in renal function.
Shoji T, Wada A, Inoue K, Hayashi D, Tomida K, Furumatsu Y, Kaneko T, Okada N, Fukuhara Y, Imai E, Tsubakihara Y. Shoji T, et al. Among authors: imai e. Nephron Clin Pract. 2007;105(3):c99-107. doi: 10.1159/000097985. Epub 2006 Dec 15. Nephron Clin Pract. 2007. PMID: 17179734 Clinical Trial.
Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease.
Imai E, Horio M, Nitta K, Yamagata K, Iseki K, Hara S, Ura N, Kiyohara Y, Hirakata H, Watanabe T, Moriyama T, Ando Y, Inaguma D, Narita I, Iso H, Wakai K, Yasuda Y, Tsukamoto Y, Ito S, Makino H, Hishida A, Matsuo S. Imai E, et al. Clin Exp Nephrol. 2007 Mar;11(1):41-50. doi: 10.1007/s10157-006-0453-4. Epub 2007 Mar 28. Clin Exp Nephrol. 2007. PMID: 17384997
Effect of renin-angiotensin-aldosterone system triple blockade on non-diabetic renal disease: addition of an aldosterone blocker, spironolactone, to combination treatment with an angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker.
Furumatsu Y, Nagasawa Y, Tomida K, Mikami S, Kaneko T, Okada N, Tsubakihara Y, Imai E, Shoji T. Furumatsu Y, et al. Among authors: imai e. Hypertens Res. 2008 Jan;31(1):59-67. doi: 10.1291/hypres.31.59. Hypertens Res. 2008. PMID: 18360019 Clinical Trial.
533 results